These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15634904)

  • 21. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells.
    Oliver AM; Martin F; Kearney JF
    J Immunol; 1999 Jun; 162(12):7198-207. PubMed ID: 10358166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired intracellular calcium mobilization and NFATc1 availability in tolerant anti-insulin B cells.
    Acevedo-Suárez CA; Kilkenny DM; Reich MB; Thomas JW
    J Immunol; 2006 Aug; 177(4):2234-41. PubMed ID: 16887983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversing Tolerance in Isotype Switch-Competent Anti-Insulin B Lymphocytes.
    Williams JM; Bonami RH; Hulbert C; Thomas JW
    J Immunol; 2015 Aug; 195(3):853-64. PubMed ID: 26109644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-affinity anti-Smith antigen B cells are regulated by anergy as opposed to developmental arrest or differentiation to B-1.
    Borrero M; Clarke SH
    J Immunol; 2002 Jan; 168(1):13-21. PubMed ID: 11751941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells.
    Attanavanich K; Kearney JF
    J Immunol; 2004 Jan; 172(2):803-11. PubMed ID: 14707050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B cell receptor affinity and B cell subset identity integrate to define the effectiveness, affinity threshold, and mechanism of anergy.
    Diz R; McCray SK; Clarke SH
    J Immunol; 2008 Sep; 181(6):3834-40. PubMed ID: 18768837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel roles for Lyn in B cell migration and lipopolysaccharide responsiveness revealed using anti-double-stranded DNA Ig transgenic mice.
    Seo S; Buckler J; Erikson J
    J Immunol; 2001 Mar; 166(6):3710-6. PubMed ID: 11238611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells.
    Rathmell JC; Fournier S; Weintraub BC; Allison JP; Goodnow CC
    J Exp Med; 1998 Aug; 188(4):651-9. PubMed ID: 9705947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of tolerance of anti-dsDNA B cells in mice overexpressing CD19.
    Taylor DK; Ito E; Thorn M; Sundar K; Tedder T; Spatz LA
    Mol Immunol; 2006 Apr; 43(11):1776-90. PubMed ID: 16430962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of a V region-less B cell receptor confers a tolerance-like phenotype on transgenic B cells.
    Corcos D; Grandien A; Vazquez A; Dunda O; Lorès P; Bucchini D
    J Immunol; 2001 Mar; 166(5):3083-9. PubMed ID: 11207259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anergic T cells inhibit the antigen-presenting function of dendritic cells.
    Vendetti S; Chai JG; Dyson J; Simpson E; Lombardi G; Lechler R
    J Immunol; 2000 Aug; 165(3):1175-81. PubMed ID: 10903714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anergy and not clonal ignorance determines the fate of B cells that recognize a physiological autoantigen.
    Rojas M; Hulbert C; Thomas JW
    J Immunol; 2001 Mar; 166(5):3194-200. PubMed ID: 11207272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirements for follicular exclusion and competitive elimination of autoantigen-binding B cells.
    Ekland EH; Forster R; Lipp M; Cyster JG
    J Immunol; 2004 Apr; 172(8):4700-8. PubMed ID: 15067045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural autoreactive B cells in transgenic mice reproduce an apparent paradox to the clonal tolerance theory.
    Koenig-Marrony S; Soulas P; Julien S; Knapp AM; Garaud JC; Martin T; Pasquali JL
    J Immunol; 2001 Feb; 166(3):1463-70. PubMed ID: 11160185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
    Prud'homme GJ; Chang Y; Li X
    Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation.
    Nickerson KM; Christensen SR; Cullen JL; Meng W; Luning Prak ET; Shlomchik MJ
    J Immunol; 2013 Feb; 190(4):1447-56. PubMed ID: 23296704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bruton's tyrosine kinase promotes persistence of mature anti-insulin B cells.
    Bonami RH; Sullivan AM; Case JB; Steinberg HE; Hoek KL; Khan WN; Kendall PL
    J Immunol; 2014 Feb; 192(4):1459-70. PubMed ID: 24453243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An intrinsic B-cell defect supports autoimmunity in New Zealand black chromosome 13 congenic mice.
    Loh C; Pau E; Chang NH; Wither JE
    Eur J Immunol; 2011 Feb; 41(2):527-36. PubMed ID: 21268021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transgenic expression of a human polyreactive Ig expressed in chronic lymphocytic leukemia generates memory-type B cells that respond to nonspecific immune activation.
    Widhopf GF; Brinson DC; Kipps TJ; Tighe H
    J Immunol; 2004 Feb; 172(4):2092-9. PubMed ID: 14764674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice.
    Steptoe RJ; Ritchie JM; Harrison LC
    J Immunol; 2002 May; 168(10):5032-41. PubMed ID: 11994455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.